Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry
Kathleen Maksimowicz-McKinnon, Faith Selzer, Susan Manzi, Kevin E Kip, Suresh R Mulukutla, Oscar C Marroquin, Thomas C Smitherman, Lewis H Kuller, David O Williams and Mary Chester M Wasko
Circulation. Cardiovascular interventions, v 1(3), pp 201-208
Women with systemic lupus erythematosus (SLE) have premature and accelerated atherosclerosis. Although percutaneous coronary intervention (PCI) is used frequently to treat coronary artery disease in SLE, little is known regarding PCI outcomes immediately after PCI and after discharge.
Baseline demographic, procedure-related, and adverse outcome data on consecutive patients undergoing PCI during 5 recruitment "waves" of the National Heart, Lung, and Blood Institute Dynamic Registry across 23 clinical centers were collected. SLE patients (n=28) were compared with non-SLE patients (n=3385). SLE patients were younger and more often female in comparison with non-SLE patients undergoing PCI. SLE patients were less likely than non-SLE patients to have hyperlipidemia but had a similar prevalence of hypertension, diabetes mellitus, and tobacco use. The prevalence of multivessel disease was similar between groups. Initial intervention success (by angiographic definition) was not significantly different between groups. At 1 year, SLE patients were more likely to experience a myocardial infarction (15.6% versus 4.8%, P=0.01) and more often required repeat PCI (31.3% versus 11.8%, P=0.009) than non-SLE patients, even after adjustment for important covariates.
SLE patients had significantly worse cardiovascular outcomes at 1 year than non-SLE patients. Even considering the small number of SLE patients, these differences were striking. Further study is warranted to explore other factors potentially accounting for this disparity, including SLE disease activity and duration, presence of hypercoagulable state, and immunosuppressive therapy.
Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry
Creators
Kathleen Maksimowicz-McKinnon - University of Pittsburgh
Faith Selzer - Rhode Island Hospital
Susan Manzi - University of South Florida
Kevin E Kip - University of South Florida
Suresh R Mulukutla - University of Pittsburgh
Oscar C Marroquin - University of South Florida
Thomas C Smitherman - University of South Florida
Lewis H Kuller - University of Pittsburgh
David O Williams - University of South Florida
Mary Chester M Wasko - University of South Florida
Publication Details
Circulation. Cardiovascular interventions, v 1(3), pp 201-208